Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Hib-meningococcal vaccine groups A and C polysaccharide conjugate - Chongqing Zhifei Biological Products

Next Previous
Drug Profile

Hib-meningococcal vaccine groups A and C polysaccharide conjugate - Chongqing Zhifei Biological Products

Alternative Names: Hib-Group A and C meningococcal polysaccharide conjugate vaccine - Chongqing Zhifei Biological Products; HibACon - Chongqing Zhifei Biological Products; MenAC-Hib - Chongqing Zhifei Biological Products

Latest Information Update: 06 Oct 2016

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Chongqing Zhifei Biological Products
  • Class Conjugate vaccines; Haemophilus vaccines; Meningococcal vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Haemophilus infections; Meningococcal group A infections; Meningococcal group C infections

Most Recent Events

  • 01 Aug 2016 Chongqing Zhifei Biological Products initiates a phase I/II trial in Haemophilus infections, Meningococcal group A infections and Meningococcal group C infections (Prevention, In infants) in China (IM) (NCT02919293)
  • 05 Jun 2015 Phase III development is ongoing in China
  • 30 Oct 2012 Phase-III clinical trials in Haemophilus infections (In children, In infants, Prevention) in China (IM)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top